Tolerance Bio

Seed
tolerancebio.com Biotech & Healthcare
Total Funding $17.2M
Latest Round $17.2M Seed
Last Announced Oct 15, 2024
Investors Undisclosed
Decision Makers 6 Verified

About Tolerance Bio

Tolerance Bio will increase health span by preserving and restoring the function of the thymus, the master regulator of immune tolerance. Immune-mediated diseases represent a significant unmet medical challenge: cancer, autoimmunity, transplant rejection, infections, immune deficiencies, and allergi

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Seed
Global Headquarters Undisclosed
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website tolerancebio.com
Domain Registered Date Feb 26, 2021

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised $17,200,000 · Seed

    fundraisingfox.com

  2. Milestone

    Website domain registered

    tolerancebio.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Tolerance Bio.

Funding History

1 Round
Seed · Oct 15, 2024

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts